// April 18, 2024
USP’s commitment to ESG considerations for a healthier, more sustainable world
At the U.S.
At the U.S.
The development of generic versions of innovator medicines is a global public health need.
Generic medicines have benefited millions of Americans and saved trillions of dollars.
We live in an age where the use of computers and software systems are directly integrated into th